OI
Onconetix, Inc.
SEC filingBiotechnology · Cincinnati, OH
Amount raised$13Msold at filing
Total offering$13M
Investors in the raise11count reported to the SEC
FiledOct 7, 2025first sale Sep 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Simon TarshDirector
Karina FedaszExecutive Officer
Andrew OakleyDirector
Timothy RamdeenDirector
Thomas MeierDirector
Executive officers, directors and promoters as listed on the Form D.